In 2018, Lei et al. found that the LIFR protein level was significantly lower in 25 tumor samples compared to normal matched samples (p < 0.001), while transcriptomic data from TCGA showed that LIFR mRNA levels were significantly lower in tumor samples than in normal samples (p < 0.001) [36]. This evidence concerns the gene LIFR and neoplasm.